Johns Hopkins selects Digisonics for cardiac study

Kaitlyn Dmyterko | | Health Imaging | Practice Management
The Coronary Artery Risk Development in Young Adults (CARDIA) study performed at Johns Hopkins University School of Medicine in Baltimore will utilize Digisonics’ DigiView Image Management and Reporting System to record study data.

The study will investigate how lifestyle decisions affect cardiovascular disease in young adults.

The Houston-based Digisonics said the DigiView system features quantification capabilities, a clinical database and PACS image archive and interface capacity for video-to-digital conversion using VCRs and DVDs.

In addition, Johns Hopkins will use DigiView Search software to mine and locate study data, according to the company.

Kaitlyn Dmyterko

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.